Trinity Biotech (TRIB) news

Trinity Biotech provides diagnostics business, transformation and corporate update

Trinity Biotech, a publicly traded diagnostics company listed on NASDAQ, continues to expand its global footprint through a combination of direct sales in the United States and strategic partners across 100 countries . The company, which was founded in 1992 and has headquarters in Bray, Co.…

Trinity Biotech secures additional $7.0 million investment from Perceptive Advisors and regains compliance with Nasdaq minimum bid price requirement

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, has announced a series of financial and structural developments aimed at strengthening its balance sheet and ensuring continued compliance with Nasdaq listing…

Trinity Biotech - ADS ratio change effective July 24, 2026

Trinity Biotech - ADS to continue trading on Nasdaq under symbol TRIB

Trinity Biotech - American Depositary Shares (ADS) will continue trading on the Nasdaq under the symbol TRIB[1]. This arrangement allows U.S. investors to hold and trade shares in the company through the ADS mechanism, which facilitates cross-border investment by converting local shares into a…

Trinity Biotech - to change ADS ratio from 1:20 to 1:600

Trinity Biotech plc (NASDAQ: TRIB) has announced a further adjustment to the ratio of its American depositary shares (ADSs), changing from one (1) ADS representing twenty (20) Class A ordinary shares to one (1) ADS representing six hundred (600) Class A ordinary shares. This change effectively…